Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034541 | 12703454 | 1 | I | 20160822 | 20160831 | 20160831 | EXP | CN-JNJFOC-20160819189 | JANSSEN | XU H. 10 CASES OF FENTANYL TRANSDERMAL SYSTEM-INDUCED ADVERSE REACTIONS. MEDICAL FRONTIER AUG-2016;6/23:186-187. | 0.00 | Y | 0.00000 | 20160831 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034541 | 12703454 | 1 | PS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | U | U | 19813 | PATCH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127034541 | 12703454 | 1 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127034541 | 12703454 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127034541 | 12703454 | Application site pain | |
| 127034541 | 12703454 | Application site rash | |
| 127034541 | 12703454 | Hyperhidrosis | |
| 127034541 | 12703454 | Loss of consciousness | |
| 127034541 | 12703454 | Mental disorder | |
| 127034541 | 12703454 | Seizure | |
| 127034541 | 12703454 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |